{"id":485,"date":"2023-12-18T03:05:58","date_gmt":"2023-12-18T03:05:58","guid":{"rendered":"http:\/\/www.wallstreetendeavor.loc\/?p=485"},"modified":"2024-05-13T14:13:57","modified_gmt":"2024-05-13T14:13:57","slug":"genequantum-and-biomap-strategic-collaboration","status":"publish","type":"post","link":"https:\/\/wallstreetendeavor.com\/de\/pharmaceutical\/genequantum-and-biomap-strategic-collaboration\/","title":{"rendered":"GeneQuantum and BioMap Strategic Collaboration"},"content":{"rendered":"<p>GeneQuantum Healthcare, a leader in ADC (Antibody-Drug Conjugate) new drug development, has entered into a strategic collaboration with BioMap, renowned for its AI in life sciences. This partnership aims to co-develop ADC therapeutics using GeneQuantum&#8217;s enzymatic site-specific conjugation technology and BioMap&#8217;s AI capabilities. This collaboration is set to redefine the landscape of ADC drug development, focusing on enhancing R&amp;D efficiency, reducing development costs, and advancing high-quality therapeutics to meet global medical needs<\/p>","protected":false},"excerpt":{"rendered":"<p>GeneQuantum Healthcare, a leader in ADC (Antibody-Drug Conjugate) new drug development, has entered into a strategic collaboration with BioMap, renowned for its AI in life sciences. This partnership aims to co-develop ADC therapeutics using GeneQuantum&#8217;s enzymatic site-specific conjugation technology and BioMap&#8217;s AI capabilities. This collaboration is set to redefine the landscape of ADC drug development, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1211,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15,7,9],"tags":[],"class_list":["post-485","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ai","category-pharmaceutical","category-technology"],"acf":{"featured_video_oembed":"","featured_post_summary":"","post_source":""},"_links":{"self":[{"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/posts\/485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/comments?post=485"}],"version-history":[{"count":1,"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/posts\/485\/revisions"}],"predecessor-version":[{"id":486,"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/posts\/485\/revisions\/486"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/media\/1211"}],"wp:attachment":[{"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/media?parent=485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/categories?post=485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wallstreetendeavor.com\/de\/wp-json\/wp\/v2\/tags?post=485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}